According to him, there are “preclinical studies”, there are several platforms on which these vaccines are developed.

“There are encouraging results that we will come to a drug that will work,” RIA Novosti quoted the minister as saying.

In mid-April, Murashko noted that seven centers were developing the vaccine in Russia, and announced early clinical trials.